Literature DB >> 34561691

A practical guide to large-scale docking.

Brian J Bender1, Stefan Gahbauer1, Andreas Luttens2, Jiankun Lyu1, Chase M Webb1, Reed M Stein1, Elissa A Fink1, Trent E Balius3, Jens Carlsson2, John J Irwin1, Brian K Shoichet4.   

Abstract

Structure-based docking screens of large compound libraries have become common in early drug and probe discovery. As computer efficiency has improved and compound libraries have grown, the ability to screen hundreds of millions, and even billions, of compounds has become feasible for modest-sized computer clusters. This allows the rapid and cost-effective exploration and categorization of vast chemical space into a subset enriched with potential hits for a given target. To accomplish this goal at speed, approximations are used that result in undersampling of possible configurations and inaccurate predictions of absolute binding energies. Accordingly, it is important to establish controls, as are common in other fields, to enhance the likelihood of success in spite of these challenges. Here we outline best practices and control docking calculations that help evaluate docking parameters for a given target prior to undertaking a large-scale prospective screen, with exemplification in one particular target, the melatonin receptor, where following this procedure led to direct docking hits with activities in the subnanomolar range. Additional controls are suggested to ensure specific activity for experimentally validated hit compounds. These guidelines should be useful regardless of the docking software used. Docking software described in the outlined protocol (DOCK3.7) is made freely available for academic research to explore new hits for a range of targets.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34561691      PMCID: PMC8522653          DOI: 10.1038/s41596-021-00597-z

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   17.021


  94 in total

Review 1.  The influence of lead discovery strategies on the properties of drug candidates.

Authors:  György M Keserü; Gergely M Makara
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

Review 2.  Novel trends in high-throughput screening.

Authors:  Lorenz M Mayr; Dejan Bojanic
Journal:  Curr Opin Pharmacol       Date:  2009-09-21       Impact factor: 5.547

3.  Proceedings of clinical meeting of the Dermatological Society, India. Tamil Nadu Branch.

Authors: 
Journal:  Indian J Dermatol       Date:  1972-07       Impact factor: 1.494

4.  Immunosuppresive effect of a human hepatic glycoferroprotein, alpha2H globulin. A study on the transformation of normal human lymphocytes.

Authors:  D Buffe; C Rimbaut
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

5.  Salt effects on polyelectrolyte-ligand binding: comparison of Poisson-Boltzmann, and limiting law/counterion binding models.

Authors:  K A Sharp; R A Friedman; V Misra; J Hecht; B Honig
Journal:  Biopolymers       Date:  1995-08       Impact factor: 2.505

6.  Ultra-large library docking for discovering new chemotypes.

Authors:  Jiankun Lyu; Sheng Wang; Trent E Balius; Isha Singh; Anat Levit; Yurii S Moroz; Matthew J O'Meara; Tao Che; Enkhjargal Algaa; Kateryna Tolmachova; Andrey A Tolmachev; Brian K Shoichet; Bryan L Roth; John J Irwin
Journal:  Nature       Date:  2019-02-06       Impact factor: 49.962

7.  Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.

Authors:  Reed M Stein; Hye Jin Kang; John D McCorvy; Grant C Glatfelter; Anthony J Jones; Tao Che; Samuel Slocum; Xi-Ping Huang; Olena Savych; Yurii S Moroz; Benjamin Stauch; Linda C Johansson; Vadim Cherezov; Terry Kenakin; John J Irwin; Brian K Shoichet; Bryan L Roth; Margarita L Dubocovich
Journal:  Nature       Date:  2020-02-10       Impact factor: 49.962

8.  SAVI, in silico generation of billions of easily synthesizable compounds through expert-system type rules.

Authors:  Hitesh Patel; Wolf-Dietrich Ihlenfeldt; Philip N Judson; Yurii S Moroz; Yuri Pevzner; Megan L Peach; Victorien Delannée; Nadya I Tarasova; Marc C Nicklaus
Journal:  Sci Data       Date:  2020-11-11       Impact factor: 6.444

9.  Generating Multibillion Chemical Space of Readily Accessible Screening Compounds.

Authors:  Oleksandr O Grygorenko; Dmytro S Radchenko; Igor Dziuba; Alexander Chuprina; Kateryna E Gubina; Yurii S Moroz
Journal:  iScience       Date:  2020-10-15

10.  An open-source drug discovery platform enables ultra-large virtual screens.

Authors:  Andras Boeszoermenyi; Zi-Fu Wang; Christoph Gorgulla; Patrick D Fischer; Paul W Coote; Krishna M Padmanabha Das; Yehor S Malets; Dmytro S Radchenko; Yurii S Moroz; David A Scott; Konstantin Fackeldey; Moritz Hoffmann; Iryna Iavniuk; Gerhard Wagner; Haribabu Arthanari
Journal:  Nature       Date:  2020-03-09       Impact factor: 49.962

View more
  25 in total

1.  Systemic evolutionary chemical space exploration for drug discovery.

Authors:  Chong Lu; Shien Liu; Weihua Shi; Jun Yu; Zhou Zhou; Xiaoxiao Zhang; Xiaoli Lu; Faji Cai; Ning Xia; Yikai Wang
Journal:  J Cheminform       Date:  2022-04-01       Impact factor: 5.514

2.  New insights into geraniol's antihemolytic, anti-inflammatory, antioxidant, and anticoagulant potentials using a combined biological and in silico screening strategy.

Authors:  Eman Fawzy El Azab; Shaymaa Abdulmalek; Abdulrahman M Saleh; Sara Osman Yousif; Bi Bi Zainab Mazhari; Heba Abu Alrub; Elyasa Mustafa Elfaki; Alneil Hamza
Journal:  Inflammopharmacology       Date:  2022-08-06       Impact factor: 5.093

3.  Development of an automated screen for Kv7.2 potassium channels and discovery of a new agonist chemotype.

Authors:  Ciria C Hernandez; Rahilla A Tarfa; Jose Miguel I Limcaoco; Ruiting Liu; Pravat Mondal; Clare Hill; R Keith Duncan; Thanos Tzounopoulos; Corey R J Stephenson; Matthew J O'Meara; Peter Wipf
Journal:  Bioorg Med Chem Lett       Date:  2022-06-04       Impact factor: 2.940

Review 4.  Insights into the Pharmacological Effects of Flavonoids: The Systematic Review of Computer Modeling.

Authors:  Amir Taldaev; Roman Terekhov; Ilya Nikitin; Anastasiya Zhevlakova; Irina Selivanova
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

5.  Anticancer potential of β-sitosterol and oleanolic acid as through inhibition of human estrogenic 17beta-hydroxysteroid dehydrogenase type-1 based on an in silico approach.

Authors:  Alfinda Novi Kristanti; Nanik Siti Aminah; Imam Siswanto; Yosephine Sri Wulan Manuhara; Muhammad Ikhlas Abdjan; Andika Pramudya Wardana; Ei Ei Aung; Yoshiaki Takaya
Journal:  RSC Adv       Date:  2022-07-13       Impact factor: 4.036

6.  3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors.

Authors:  Vikas Kumar; Shraddha Parate; Amir Zeb; Pooja Singh; Gihwan Lee; Tae Sung Jung; Keun Woo Lee; Min Woo Ha
Journal:  Front Cell Infect Microbiol       Date:  2022-06-30       Impact factor: 6.073

7.  Structure-based inhibitor optimization for the Nsp3 Macrodomain of SARS-CoV-2.

Authors:  Stefan Gahbauer; Galen J Correy; Marion Schuller; Matteo P Ferla; Yagmur Umay Doruk; Moira Rachman; Taiasean Wu; Morgan Diolaiti; Siyi Wang; R Jeffrey Neitz; Daren Fearon; Dmytro Radchenko; Yurii Moroz; John J Irwin; Adam R Renslo; Jenny C Taylor; Jason E Gestwicki; Frank von Delft; Alan Ashworth; Ivan Ahel; Brian K Shoichet; James S Fraser
Journal:  bioRxiv       Date:  2022-06-28

Review 8.  Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.

Authors:  Md Rifat Hasan; Ahad Amer Alsaiari; Burhan Zain Fakhurji; Mohammad Habibur Rahman Molla; Amer H Asseri; Md Afsar Ahmed Sumon; Moon Nyeo Park; Foysal Ahammad; Bonglee Kim
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

9.  Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1-Nrf2 Protein-Protein Interaction.

Authors:  Fabio Begnini; Stefan Geschwindner; Patrik Johansson; Lisa Wissler; Richard J Lewis; Emma Danelius; Andreas Luttens; Pierre Matricon; Jens Carlsson; Stijn Lenders; Beate König; Anna Friedel; Peter Sjö; Stefan Schiesser; Jan Kihlberg
Journal:  J Med Chem       Date:  2022-02-02       Impact factor: 7.446

10.  New Inhibitors of Laccase and Tyrosinase by Examination of Cross-Inhibition between Copper-Containing Enzymes.

Authors:  Dinesh Chaudhary; Fangchen Chong; Trilok Neupane; Joonhyeok Choi; Jun-Goo Jee
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.